Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru

被引：49

作者：

Abugattas, J. ^{[1
]}

Llacuachaqui, M. ^{[2
]}

Allende, Y. Sullcahuaman ^{[3
,4
]}

Velasquez, A. Arias ^{[3
]}

Velarde, R. ^{[1
]}

Cotrina, J. ^{[1
]}

Garces, M. ^{[1
]}

Leon, M. ^{[1
]}

Calderon, G. ^{[1
]}

de la Cruz, M. ^{[1
]}

Mora, P. ^{[1
]}

Royer, R. ^{[2
]}

Herzog, J. ^{[5
,6
]}

Weitzel, J. N. ^{[5
,6
]}

Narod, S. A. ^{[2
]}

机构：

[1] Inst Nacl Enfermedades Neoplas, Dept Mamas Partes Blandas & Piel, Lima, Peru

[2] Womens Coll Res Inst, Familial Breast Canc Res Unit, Toronto, ON, Canada

[3] Inst Nacl Enfermedades Neoplas, Unidad Genet & Biol Mol, Lima, Peru

[4] Univ Peruana Ciencias Aplicadas, Escuela Med, Lima, Peru

[5] City Hope Natl Med Ctr, Comprehens Canc Ctr, Duarte, CA USA

[6] City Hope Natl Med Ctr, Beckman Res Inst, Div Clin Canc Genet, Duarte, CA 91010 USA

来源：

CLINICAL GENETICS | 2015年 / 88卷 / 04期

关键词：

Peru; breast cancer; hereditary; BRCA1; BRCA2; BREAST/OVARIAN CANCER; FAMILY-HISTORY; RISKS; ASSOCIATION; WOMEN;

D O I：

10.1111/cge.12505

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

The prevalence of BRCA1 and BRCA2 mutations among breast cancer patients in Peru has not yet been explored. We enrolled 266 women with breast cancer from a National cancer hospital in Lima, Peru, unselected for age or family history. DNA was screened with a panel of 114 recurrent Hispanic BRCA mutations (HISPANEL). Among the 266 cases, 13 deleterious mutations were identified (11 in BRCA1 and 2 in BRCA2), representing 5% of the total. The average age of breast cancer in the mutation-positive cases was 44 years. BRCA1 185delAG represented 7 of 11 mutations in BRCA1. Other mutations detected in BRCA1 included: two 2080delA, one 943ins10, and one 3878delTA. The BRCA2 3036del4 mutation was seen in two patients. Given the relatively low cost of the HISPANEL test, one should consider offering this test to all Peruvian women with breast or ovarian cancer.

引用

页码：371 / 375

页数：5

共 50 条

[41] BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancer
Gershoni-Baruch, R
Dagan, E
Fried, G
Kepten, I
Robinson, E
EUROPEAN JOURNAL OF HUMAN GENETICS, 1999, 7 (07) : 833 - 836
[42] Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in hungary
Van der Looij, M
Szabo, C
Besznyak, I
Liszka, G
Csokay, B
Pulay, T
Toth, J
Devilee, P
King, MC
Olah, E
INTERNATIONAL JOURNAL OF CANCER, 2000, 86 (05) : 737 - 740
[43] Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer
Wong-Brown, Michelle W.
Meldrum, Cliff J.
Carpenter, Jane E.
Clarke, Christine L.
Narod, Steven A.
Jakubowska, Anna
Rudnicka, Helena
Lubinski, Jan
Scott, Rodney J.
BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (01) : 71 - 80
[44] Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer
Michelle W. Wong-Brown
Cliff J. Meldrum
Jane E. Carpenter
Christine L. Clarke
Steven A. Narod
Anna Jakubowska
Helena Rudnicka
Jan Lubinski
Rodney J. Scott
Breast Cancer Research and Treatment, 2015, 150 : 71 - 80
[45] Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer
Peto, J
Collins, N
Barfoot, R
Seal, S
Warren, W
Rahman, N
Easton, DF
Evans, C
Deacon, J
Stratton, MR
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (11) : 943 - 949
[46] Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients
Syrjäkoski, K
Vahteristo, P
Eerola, H
Tamminen, A
Kivinummi, K
Sarantaus, L
Holli, K
Blomqvist, C
Kallioniemi, OP
Kainu, T
Nevanlinna, H
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (18) : 1529 - 1531
[47] High proportion of germline BRCA1 and BRCA2 mutations in unselected ovarian cancer
Abrahamson, JLA
Vesprini, DJ
Mclaughlin, J
Cole, D
Rosen, B
Bradley, L
Robb, K
Jack, E
Rehal, P
Morris, A
Patterson, C
Fan, I
Brunel, JS
Narod, SA
Risch, HA
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A59 - A59
[48] Prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations
Roukos, Dimitrios H.
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (15): : 1555 - 1556
[49] Breast cancer survival in carriers of BRCA1 and BRCA2 mutations
Rennert, G.
Bisland, S.
Bar Joseph, N.
Zhang, S.
Rennert, H. S.
Barnett-Griness, O.
Narod, S. A.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[50] Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia
Wafa Troudi
N. Uhrhammer
C. Sibille
C. Dahan
W. Mahfoudh
C. Bouchlaka Souissi
T. Jalabert
L. Chouchane
Y. J. Bignon
F. Ben Ayed
A. Ben Ammar Elgaaied
Journal of Human Genetics, 2007, 52 : 915 - 920

← 1 2 3 4 5 →